Charles Morgan Kendrick Jr. is President & VP at Elevance Health, Inc. (ELV). They have made 6 open-market trades across 2 companies since 2022, most recently 2026-03-06.
CIK 0001887908
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANTM | 14,529 | $7.0M |
| ELV | 11,791 | $5.1M |
| Total | $12.1M |
Shares reported on the most recent Form 4, priced at the 2026-03-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELV | SELL | 2026-03-06 | 2026-03-09 | $284.92 | $911K | +1.4% | +10.8% | +45.6% |
| ELV | SELL | 2025-03-05 | 2025-03-05 | $396.30 | $2.8M | +8.2% | +7.8% | -4.7% |
| ELV | SELL | 2024-10-18 | 2024-10-18 | $432.14 | $6.4M | -4.1% | -6.4% | -10.0% |
| ELV | SELL | 2024-03-08 | 2024-03-12 | $500.46 | $2.4M | +1.1% | -1.3% | +5.5% |
| ELV | SELL | 2023-03-09 | 2023-03-13 | $462.22 | $2.1M | -3.1% | +7.1% | +2.7% |
| ANTM | SELL | 2022-06-09 | 2022-06-13 | $488.84 | $5.1M | +2.1% | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.